The ONE Disease That Smoking Can Help Treat

TL;DR

Smoking reduces ulcerative colitis inflammation because benzene byproduct hydroquinone allows mouth bacteria Streptococcus mitis to colonize the colon and suppress the immune cells driving UC.

Key Points

• 1.Smoking has opposite effects on the two main forms of IBD. It reduces ulcerative colitis risk by 3–6x compared to non-smokers, yet worsens Crohn's disease symptoms, increasing flare-ups, hospital stays, and need for surgery.
• 2.UC and Crohn's differ in which immune cells cause damage. Crohn's is driven by TH1 cells, while UC is driven by atypical TH2 cells — a distinction that explains why the same trigger can help one disease and harm the other.
• 3.Streptococcus mitis, a common mouth bacterium, is the key mechanism. Researchers at RIKEN found it present in unusually high amounts in the colons of UC smokers; introducing it to UC mice reduced inflammation, but worsened Crohn's mice by boosting TH1 cells that counter TH2 activity.
• 4.Hydroquinone, a benzene metabolite from tobacco smoke, enables the effect. It suppresses gut immunity, allowing Strep mitis to survive and grow in the colon rather than pass through; a 2014 mouse study using oral hydroquinone (zonarol) showed fewer ulcers, less inflammation, and fewer disease symptoms.
• 5.Smoking itself is not a recommended treatment, but targeted therapies are being explored. Proposed options include directly transplanting Strep mitis into UC patients' colons or developing a safe oral hydroquinone formulation — though no liver-safe human version currently exists and neither approach is clinically approved.